ID   GBA2_RAT                Reviewed;         912 AA.
AC   Q5M868;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   02-OCT-2024, entry version 108.
DE   RecName: Full=Non-lysosomal glucosylceramidase {ECO:0000305};
DE            Short=NLGase {ECO:0000250|UniProtKB:Q9HCG7};
DE            EC=3.2.1.45 {ECO:0000250|UniProtKB:Q9HCG7};
DE   AltName: Full=Beta-glucocerebrosidase 2;
DE            Short=Beta-glucosidase 2;
DE   AltName: Full=Bile acid beta-glucosidase GBA2 {ECO:0000250|UniProtKB:Q9HCG7};
DE   AltName: Full=Bile acid glucosyl transferase GBA2 {ECO:0000250|UniProtKB:Q9HCG7};
DE   AltName: Full=Cholesterol glucosyltransferase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};
DE            EC=2.4.1.- {ECO:0000250|UniProtKB:Q69ZF3};
DE   AltName: Full=Cholesteryl-beta-glucosidase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};
DE            EC=3.2.1.- {ECO:0000250|UniProtKB:Q69ZF3};
DE   AltName: Full=Glucosylceramidase 2;
DE   AltName: Full=Non-lysosomal cholesterol glycosyltransferase {ECO:0000305};
DE   AltName: Full=Non-lysosomal galactosylceramidase {ECO:0000305};
DE            EC=3.2.1.46 {ECO:0000250|UniProtKB:Q9HCG7};
DE   AltName: Full=Non-lysosomal glycosylceramidase {ECO:0000305};
GN   Name=Gba2 {ECO:0000312|RGD:1305598};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Non-lysosomal glucosylceramidase that catalyzes the
CC       hydrolysis of glucosylceramides/GlcCers (such as beta-D-glucosyl-
CC       (1<->1')-N-acylsphing-4-enine) to free glucose and ceramides (such as
CC       N-acylsphing-4-enine) (By similarity). GlcCers are membrane
CC       glycosphingolipids that have a wide intracellular distribution (By
CC       similarity). They are the main precursors of more complex
CC       glycosphingolipids that play a role in cellular growth,
CC       differentiation, adhesion, signaling, cytoskeletal dynamics and
CC       membrane properties (By similarity). Involved in the transglucosylation
CC       of cholesterol, transfers glucose from GlcCer to cholesterol, thereby
CC       modifying its water solubility and biological properties (By
CC       similarity). Under specific conditions, may catalyze the reverse
CC       reaction, transferring glucose from cholesteryl-3-beta-D-glucoside to
CC       ceramide (such as N-acylsphing-4-enine). May play a role in the
CC       metabolism of bile acids. Able to hydrolyze bile acid 3-O-glucosides as
CC       well as to produce bile acid-glucose conjugates thanks to a bile acid
CC       glucosyl transferase activity. Catalyzes the hydrolysis of
CC       galactosylceramides/GalCers (such as beta-D-galactosyl-(1<->1')-N-
CC       acylsphing-4-enine), as well as the galactosyl transfer between GalCers
CC       and cholesterol in vitro with lower activity compared with their
CC       activity against GlcCers (By similarity).
CC       {ECO:0000250|UniProtKB:Q69ZF3, ECO:0000250|UniProtKB:Q9HCG7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + H2O = an N-
CC         acylsphing-4-enine + D-glucose; Xref=Rhea:RHEA:13269,
CC         ChEBI:CHEBI:4167, ChEBI:CHEBI:15377, ChEBI:CHEBI:22801,
CC         ChEBI:CHEBI:52639; EC=3.2.1.45;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13270;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine + H2O = an
CC         N-acylsphing-4-enine + D-galactose; Xref=Rhea:RHEA:14297,
CC         ChEBI:CHEBI:4139, ChEBI:CHEBI:15377, ChEBI:CHEBI:18390,
CC         ChEBI:CHEBI:52639; EC=3.2.1.46;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14298;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-glucosyl-(1->3)-O-lithocholate + H2O = D-glucose +
CC         lithocholate; Xref=Rhea:RHEA:58344, ChEBI:CHEBI:4167,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:29744, ChEBI:CHEBI:142611;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58345;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-glucosyl-(1->3)-O-chenodeoxycholate + H2O =
CC         chenodeoxycholate + D-glucose; Xref=Rhea:RHEA:58340,
CC         ChEBI:CHEBI:4167, ChEBI:CHEBI:15377, ChEBI:CHEBI:36234,
CC         ChEBI:CHEBI:142610; Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58341;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a di-trans,poly-cis-dolichyl beta-D-glucosyl phosphate +
CC         chenodeoxycholate = a di-trans,poly-cis-dolichyl phosphate + beta-D-
CC         glucosyl-(1->3)-O-chenodeoxycholate + H(+); Xref=Rhea:RHEA:59104,
CC         Rhea:RHEA-COMP:19498, Rhea:RHEA-COMP:19502, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:36234, ChEBI:CHEBI:57525, ChEBI:CHEBI:57683,
CC         ChEBI:CHEBI:142610; Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59105;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chenodeoxycholate + octyl beta-D-glucose = beta-D-glucosyl-
CC         (1->3)-O-chenodeoxycholate + octan-1-ol; Xref=Rhea:RHEA:59108,
CC         ChEBI:CHEBI:16188, ChEBI:CHEBI:36234, ChEBI:CHEBI:41128,
CC         ChEBI:CHEBI:142610; Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59109;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cholesteryl 3-beta-D-glucoside + H2O = cholesterol + D-
CC         glucose; Xref=Rhea:RHEA:11956, ChEBI:CHEBI:4167, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16113, ChEBI:CHEBI:17495;
CC         Evidence={ECO:0000250|UniProtKB:Q69ZF3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11957;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + cholesterol
CC         = an N-acylsphing-4-enine + cholesteryl 3-beta-D-glucoside;
CC         Xref=Rhea:RHEA:58264, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495,
CC         ChEBI:CHEBI:22801, ChEBI:CHEBI:52639;
CC         Evidence={ECO:0000250|UniProtKB:Q69ZF3};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58266;
CC         Evidence={ECO:0000250|UniProtKB:Q69ZF3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4E-enine +
CC         cholesterol = cholesteryl 3-beta-D-glucoside + N-(9Z-octadecenoyl)-
CC         sphing-4-enine; Xref=Rhea:RHEA:58324, ChEBI:CHEBI:16113,
CC         ChEBI:CHEBI:17495, ChEBI:CHEBI:77996, ChEBI:CHEBI:139140;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58325;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58326;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine +
CC         cholesterol = an N-acylsphing-4-enine + cholesteryl 3-beta-D-
CC         galactoside; Xref=Rhea:RHEA:70235, ChEBI:CHEBI:16113,
CC         ChEBI:CHEBI:18390, ChEBI:CHEBI:52639, ChEBI:CHEBI:189066;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70236;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70237;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(beta-D-galactosyl)-N-dodecanoylsphing-4-enine + cholesterol
CC         = cholesteryl 3-beta-D-galactoside + N-dodecanoylsphing-4-enine;
CC         Xref=Rhea:RHEA:70255, ChEBI:CHEBI:16113, ChEBI:CHEBI:72956,
CC         ChEBI:CHEBI:73432, ChEBI:CHEBI:189066;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70256;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70257;
CC         Evidence={ECO:0000250|UniProtKB:Q9HCG7};
CC   -!- ACTIVITY REGULATION: Enzymatic activity is dependent on membrane
CC       association and requires the presence of lipids.
CC       {ECO:0000250|UniProtKB:Q69ZF3}.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000250|UniProtKB:Q69ZF3}.
CC   -!- PATHWAY: Steroid metabolism; cholesterol metabolism.
CC       {ECO:0000250|UniProtKB:Q69ZF3}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q69ZF3}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q69ZF3}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q69ZF3}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q69ZF3}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q69ZF3}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q69ZF3}. Note=Localization to the plasma
CC       membrane and alternative topologies have also been reported.
CC       {ECO:0000250|UniProtKB:Q9HCG7}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5M868-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5M868-2; Sequence=VSP_024385, VSP_024386;
CC   -!- SIMILARITY: Belongs to the non-lysosomal glucosylceramidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03040369; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC088200; AAH88200.1; -; mRNA.
DR   AlphaFoldDB; Q5M868; -.
DR   SMR; Q5M868; -.
DR   STRING; 10116.ENSRNOP00000022002; -.
DR   CAZy; GH116; Glycoside Hydrolase Family 116.
DR   PhosphoSitePlus; Q5M868; -.
DR   PaxDb; 10116-ENSRNOP00000022002; -.
DR   UCSC; RGD:1305598; rat. [Q5M868-1]
DR   AGR; RGD:1305598; -.
DR   RGD; 1305598; Gba2.
DR   eggNOG; KOG2119; Eukaryota.
DR   InParanoid; Q5M868; -.
DR   PhylomeDB; Q5M868; -.
DR   TreeFam; TF313888; -.
DR   Reactome; R-RNO-9840310; Glycosphingolipid catabolism.
DR   UniPathway; UPA00222; -.
DR   UniPathway; UPA00296; -.
DR   PRO; PR:Q5M868; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016364; Expressed in cerebellum and 20 other cell types or tissues.
DR   ExpressionAtlas; Q5M868; baseline and differential.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0008422; F:beta-glucosidase activity; ISS:UniProtKB.
DR   GO; GO:0004336; F:galactosylceramidase activity; IEA:RHEA.
DR   GO; GO:0004348; F:glucosylceramidase activity; ISS:UniProtKB.
DR   GO; GO:0046527; F:glucosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0050295; F:steryl-beta-glucosidase activity; ISS:UniProtKB.
DR   GO; GO:0008206; P:bile acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0021954; P:central nervous system neuron development; ISS:UniProtKB.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISS:UniProtKB.
DR   GO; GO:0006680; P:glucosylceramide catabolic process; ISS:UniProtKB.
DR   GO; GO:0016139; P:glycoside catabolic process; ISS:UniProtKB.
DR   GO; GO:0030259; P:lipid glycosylation; ISS:UniProtKB.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; ISS:UniProtKB.
DR   GO; GO:0097035; P:regulation of membrane lipid distribution; ISS:UniProtKB.
DR   GO; GO:0031113; P:regulation of microtubule polymerization; ISS:UniProtKB.
DR   Gene3D; 1.50.10.10; -; 1.
DR   InterPro; IPR008928; 6-hairpin_glycosidase_sf.
DR   InterPro; IPR012341; 6hp_glycosidase-like_sf.
DR   InterPro; IPR014551; B_Glucosidase_GBA2-typ.
DR   InterPro; IPR006775; GH116_catalytic.
DR   InterPro; IPR024462; GH116_N.
DR   InterPro; IPR052566; Non-lysos_glucosylceramidase.
DR   PANTHER; PTHR12654; BILE ACID BETA-GLUCOSIDASE-RELATED; 1.
DR   PANTHER; PTHR12654:SF0; NON-LYSOSOMAL GLUCOSYLCERAMIDASE; 1.
DR   Pfam; PF04685; DUF608; 1.
DR   Pfam; PF12215; Glyco_hydr_116N; 1.
DR   PIRSF; PIRSF028944; Beta_gluc_GBA2; 1.
DR   SUPFAM; SSF48208; Six-hairpin glycosidases; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cholesterol metabolism; Endoplasmic reticulum;
KW   Glycosidase; Glycosyltransferase; Golgi apparatus; Hydrolase;
KW   Lipid metabolism; Membrane; Reference proteome; Sphingolipid metabolism;
KW   Steroid metabolism; Sterol metabolism; Transferase.
FT   CHAIN           1..912
FT                   /note="Non-lysosomal glucosylceramidase"
FT                   /id="PRO_0000283760"
FT   REGION          886..912
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        886..906
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         181..195
FT                   /note="FIVCLRRDGRTVYQQ -> VRKGAGRRRSDSWLA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024385"
FT   VAR_SEQ         196..912
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024386"
SQ   SEQUENCE   912 AA;  102747 MW;  C4A47C8C5F3D248A CRC64;
     MVTCVPASEQ IGCAERDSQI YSEDTGGTEA VRVTDCRSPE DSGPQNEPGY CNSEDSGQLM
     ASYEGKARGY QVPPFGWRIC LAHEFAEKRK PFQANNVSLS NLVKHFGMGL RYLKWWYRKT
     QVEKKTPFID MFNSVPLRQI YGCPLGGIGG GTITRGWRGQ FCRWQLNPGM YQHQTVIADQ
     FIVCLRRDGR TVYQQVLSLE LPSVLRSWNW GLCGYFAFYH ALYPRAWTVY QLPGQNVTLT
     CRQITPILPH DYQDSSLPVG VFVWDVENEG DETLDVSIMF SMRNGLGGED DAAGGLWNEP
     FRLEQDGTTV QGLLLHHPTP PNPYTMAVAA RHTADTTVTY TTAFDPDSTG QQVWQDLLQD
     GQLDSPAGQS TPTQRGEGVA GAVCASSKLL PRGRCCLEFS LAWDMPRIMF GAKGQVHYRR
     YTRFFGSDGD VAPALSHYAL CQYAGWENSI SAWQNPVLDD RSLPAWYKSA LFNELYFLAD
     GGTVWLEVPE DSLPEELGGS MYQLRPILQD YGRFGYLEGQ EYRMYNTYDV HFYASFALVM
     LWPKLELSLQ YDMALATFKE DLTRRRYLMS GVVAPVKRRN VIPHDIGDPD DEPWLRVNAY
     LIHDTADWKD LNLKFVLQVY RDYYLTGDQG FLKDMWPVCL AVMESEMKFD KDQDGLIENG
     GYADQTYDGW VTTGPSAYCG GLWLAAVAVM VQMAVLCGAQ DVQDKFSSIL CRGREAYERL
     LWNGRYYNYD SSSQPQSRSV MSDQCAGQWF LRACGLGEGD TEVFPTLHVV RALKTIFELN
     VQAFAGGAMG AVNGMQPHGV PDRSSVQSDE VWVGVVYGLA ATMIQEGLTW EGFRTAEGCY
     RTVWERLGLA FQTPEAYCQQ RVFRSLAYMR PLSIWAMQLA LQQQQHKKNS SRPAVTQGTA
     PSQPECGPKR SL
//
